Timothy J. Miller
Chief Executive Officer at Forge Biologics Holdings LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christine Silverstein | F | 41 | 8 years | |
| Brendan OMalley | M | 55 | 5 years | |
| Christopher Garabedian | M | 57 |
Forge Biologics Holdings LLC
 Forge Biologics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Forge Biologics Holdings LLC engages in the provision of biotechnology services. The company is headquartered in Grove City, OH. | - |
| Molly J. McCartin | F | - |
Forge Biologics Holdings LLC
Forge Biologics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Forge Biologics Holdings LLC engages in the provision of biotechnology services. The company is headquartered in Grove City, OH. | - |
| Brian Kevany | M | - | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Davis | M | 61 | 12 years | |
| Stephen B. Thompson | M | 70 | 3 years | |
| Joao Siffert | M | 60 | 2 years | |
| Edward Carr | M | 55 | - | |
| Mark J. Ahn | M | 61 | 11 years | |
| Edward Sturchio | M | - | 1 years | |
| Neena Patil | F | 49 | 1 years | |
| James Bircher | M | 56 | - | |
| Richard van Dyune | M | 70 | 2 years | |
| Evan A. Facher | M | - |
SironRX Therapeutics, Inc.
 SironRX Therapeutics, Inc. Hospital/Nursing ManagementHealth Services SironRX Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. Its technology is stromal cell-derived factor-1 is a naturally occurring chemokine that is rapidly over-expressed in response to tissue injury, particularly during ischemia. The firm is developing novel therapies that promote wound repair and prevent scarring of dermal wounds. The company was founded by Marc S. Penn and Rahul Aras in 2010 and is headquartered in Cleveland, OH. | - |
| Stefano Buono | M | 57 | 2 years | |
| F. Carsten Thiel | M | 61 | - | |
| Marc Penn | M | - |
SironRX Therapeutics, Inc.
SironRX Therapeutics, Inc. Hospital/Nursing ManagementHealth Services SironRX Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. Its technology is stromal cell-derived factor-1 is a naturally occurring chemokine that is rapidly over-expressed in response to tissue injury, particularly during ischemia. The firm is developing novel therapies that promote wound repair and prevent scarring of dermal wounds. The company was founded by Marc S. Penn and Rahul Aras in 2010 and is headquartered in Cleveland, OH. | - |
| Juan Ruiz | M | - | - | |
| Jodie Gillon | F | - | 2 years | |
| Victor Paulus | M | - | - | |
| Harrison Wehner | M | 59 | 3 years | |
| Rahul A. Aras | M | - |
SironRX Therapeutics, Inc.
SironRX Therapeutics, Inc. Hospital/Nursing ManagementHealth Services SironRX Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. Its technology is stromal cell-derived factor-1 is a naturally occurring chemokine that is rapidly over-expressed in response to tissue injury, particularly during ischemia. The firm is developing novel therapies that promote wound repair and prevent scarring of dermal wounds. The company was founded by Marc S. Penn and Rahul Aras in 2010 and is headquartered in Cleveland, OH. | - |
| Kaye Spratt | M | - | - | |
| Massimiliano Colao | M | 59 | 3 years | |
| Astrid Paneda Rodriguez | M | - | - | |
| Kristina Maximenko | F | - | - | |
| Scott Schorer | M | 55 | 1 years | |
| Scott Nogi | M | - | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 29 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Timothy J. Miller
- Personal Network